Takeda Pharmaceutical TAK
NYSE TAK
$17.86 -0.01 (-0.06%)
At close: Oct 2, 2026 · 4:00 PM EDT

Takeda Pharmaceutical (TAK) Non Operating Investment Income (2017 - 2019)

Updated

Takeda Pharmaceutical (TAK) posted Non Operating Investment Income of -$1.83 billion for the year ended Mar 31, 2020, compared with $34.45 million a year earlier.

Analysis

Takeda Pharmaceutical (TAK) Non Operating Investment Income (2017 - 2019) Analysis & Trends

  • Business Quant data shows TAK's Non Operating Investment Income at $34.45 million in the year ended Mar 31, 2019.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Op. Investment Inc. (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn -
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn -
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn -
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn -
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn -
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn -
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn -
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn -
10 Takeda Pharmaceutical 2.58 Bn -23.92 Bn 5.10 Bn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2019 34.45 Mn
Dec 31, 2018 -562.33 Mn
Dec 31, 2017 832.48 Mn
API Access

Takeda Pharmaceutical Non Operating Investment Income API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-operating-investment-income&ticker=TAK&period=max&api_key=YOUR_API_KEY